EXCLUSIVE: NanoViricides’ Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile
NanoViricides Inc (NYSE: NNVC) has reported significant advantages gained by remdesivir encapsulation within its lead COVID-19 candidate, thus showing a potential pan-coronavirus cure.